1,294 results match your criteria Imaging in Oligodendroglioma


Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for glioma.

Neurooncol Adv 2020 Jan-Dec;2(1):vdaa055. Epub 2020 Apr 30.

Preparing Section for New Faculty of Medical Science, Fukushima Medical University, Fukushima, Japan.

Background: High-grade glioma is the most pervasive and lethal of all brain malignancies. Despite advances in imaging technologies, discriminating between gliomas and other brain diseases such as multiple sclerosis (MS) often requires brain biopsy. Several reports show that protein tyrosine phosphatase receptor Z (PTPRZ) is highly expressed in glioblastoma, and we found that a soluble cleaved form of PTPRZ (sPTPRZ) was present in the cerebrospinal fluid (CSF). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/noajnl/vdaa055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260697PMC

Label-free multiphoton imaging allows brain tumor recognition based on texture analysis-a study of 382 tumor patients.

Neurooncol Adv 2020 Jan-Dec;2(1):vdaa035. Epub 2020 Mar 12.

Neurosurgery, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.

Background: Label-free multiphoton microscopy has been suggested for intraoperative recognition and delineation of brain tumors. For any future clinical application, appropriate approaches for image acquisition and analysis have to be developed. Moreover, an evaluation of the reliability of the approach, taking into account inter- and intrapatient variability, is needed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/noajnl/vdaa035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212881PMC

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.

Sci Rep 2020 Jun 22;10(1):10113. Epub 2020 Jun 22.

Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan.

T2-FLAIR mismatch sign is known as a highly specific imaging marker of IDH-mutant astrocytomas. This study was intended to clarify what the T2-FLAIR mismatch sign represents by pathological analysis of lower-grade gliomas rediagnosed in accordance with the WHO 2016 classification. We retrospectively analyzed the records of 64 patients diagnosed with WHO grade II and III diffuse gliomas between June 2009 and November 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-67244-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308392PMC

Role of the default mode resting-state network for cognitive functioning in malignant glioma patients following multimodal treatment.

Neuroimage Clin 2020 May 26;27:102287. Epub 2020 May 26.

Institute of Neuroscience and Medicine (INM-1, -3, -4), Research Center Juelich, Wilhelm-Johnen-Str., 52428 Juelich, Germany; Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany.

Background: Progressive cognitive decline following multimodal neurooncological treatment is a common observation in patients suffering from malignant glioma. Alterations of the default-mode network (DMN) represent a possible source of impaired neurocognitive functioning and were analyzed in these patients.

Methods: Eighty patients (median age, 51 years) with glioma (WHO grade IV glioblastoma, n = 57; WHO grade III anaplastic astrocytoma, n = 13; WHO grade III anaplastic oligodendroglioma, n = 10) and ECOG performance score 0-1 underwent resting-state functional MRI (rs-fMRI) and neuropsychological testing at a median interval of 13 months (range, 1-114 months) after initiation of therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nicl.2020.102287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298724PMC

Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series.

Front Neurosci 2020 19;14:390. Epub 2020 May 19.

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles, CA, United States.

Recently, the ketogenic diet has been proposed as an adjunct treatment for a range of medical conditions including weight loss, diabetes, cancer, and neurodegenerative diseases. Because malignant CNS tumors are highly dependent on glucose, the use of a ketogenic diet as an adjunct therapy is currently being explored. This case series summarizes our experience implementing a ketogenic diet for patients with CNS malignancies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnins.2020.00390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248360PMC

A rare case of oligodendroglioma with gangliocytic differentiation in a 31-year-old male: importance of genetic testing for IDH1/2.

Brain Tumor Pathol 2020 Jul 5;37(3):95-99. Epub 2020 Jun 5.

Department of Pathology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.

We report a rare case of oligodendroglioma with gangliocytic differentiation. A 31-year-old male without a past medical history was admitted with a sudden seizure. On magnetic resonance imaging, an approximately 7-cm mass with necrosis was noted in the right frontal lobe. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10014-020-00368-wDOI Listing

Language supplementary motor area syndrome correlated with dynamic changes in perioperative task-based functional MRI activations: case report.

J Neurosurg 2020 Jun 5:1-5. Epub 2020 Jun 5.

Departments of1Neurosurgery.

Supplementary motor area (SMA) syndrome is well known; however, the mechanism underlying recovery from language SMA syndrome is unclear. Herein the authors report the case of a right-handed woman with speech aphasia following resection of an oligodendroglioma located in the anterior aspect of the left superior frontal gyrus. The patient exhibited language SMA syndrome, and functional MRI (fMRI) findings 12 days postoperatively demonstrated a complete shift of blood oxygen level-dependent (BOLD) activation to the contralateral right language SMA/pre-SMA as well as coequal activation and an increased volume of activation in the left Broca's area and the right Broca's homolog. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2020.4.JNS193250DOI Listing

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.

BMC Cancer 2020 May 20;20(1):450. Epub 2020 May 20.

Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Background: The T2-FLAIR mismatch sign is an imaging finding highly suggestive of isocitrate dehydrogenase mutated (IDH-mut) 1p19q non-codeleted (non-codel) gliomas (astrocytomas). In previous studies, it has shown excellent specificity but limited sensitivity for IDH-mut astrocytomas. Whether the mismatch sign is a marker of a clinically relevant subtype of IDH-mut astrocytomas is unknown. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-020-06951-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238512PMC

Tc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans.

Contrast Media Mol Imaging 2020 27;2020:2525037. Epub 2020 Apr 27.

Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares (ININ), Ocoyoacac 52750, Estado de México, Mexico.

Overexpression of the chemokine-4 receptor (CXCR4) in brain tumors is associated with high cancer cell invasiveness. Recently, we reported the preclinical evaluation of Tc-CXCR4-L (cyclo-D-Tyr-D-[NMe]Orn[EDDA-Tc-6-hydrazinylnicotinyl]-Arg-NaI-Gly) as a SPECT radioligand capable of specifically detecting the CXCR4 protein. This research aimed to estimate the biokinetic behavior and radiation dosimetry of Tc-CXCR4-L in healthy subjects, as well as to correlate the radiotracer uptake by brain tumors in patients, with the histological grade of differentiation and CXCR4 expression evaluated by immunohistochemistry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/2525037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201577PMC

The biological and clinical basis for early referral of low grade glioma patients to a surgical neuro-oncologist.

J Clin Neurosci 2020 May 4. Epub 2020 May 4.

Department of Neurosurgery, University of Calgary, Alberta, Canada.

The discovery of IDH1/2 (isocitrate dehydrogenase) mutation in large scale, genomewide mutational analyses of gliomas has led to profound developments in understanding tumourigenesis, and restructuring of the classification of both high and low grade gliomas. Owing to this progress made in the recognition of molecular markers which predict tumour behavior and treatment response, the increasing importance of adjuvant treatments such as chemo- and radiotherapy, and the tremendous advances in surgical technique and intraoperative monitoring which have facilitated superior extents of resection whilst preserving neurological functioning and quality of life, contemporary management of low grade glioma (LGG) has switched from a passive, observant approach to a more active, interventional one. Furthermore, this has implications for the manner in which patients with incidentally discovered and/or asymptomatic LGG are managed, and this review of the biological behaviour of LGG, as well as its clinical investigation and management, should act as a timely reminder to all clinicians of the importance of referring LGG patients early to a surgical neuro-oncologist who is not only familiar and acquainted with the vagaries of this disease process, but who, in addition, is devoted to delivering care to these patients with the support of a multi-disciplinary clinical decision-making unit, comprising medical neuro-oncologists, radiation oncologists and allied health professionals. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2020.04.119DOI Listing

The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.

Acad Radiol 2020 Apr 28. Epub 2020 Apr 28.

Department of Neurosurgery, First Medical Center, Chinese PLA General Hospital, Beijing, China. Electronic address:

Rationale And Objectives: The classification of patients based on pathology and molecular features is important for improving WHO grade II glioma patient prognosis, especially for the initially diagnosed patients. Less invasive and more convenient methods for the prediction of the pathological type and gene status are desired.

Materials And Methods: This study investigates the ability to use conventional magnetic resonance imaging (MRI) and computed tomography (CT) features for determining the Isocitrate Dehydrogenase (IDH)-mutant and 1p/19q-codeletion status, through a retrospective review of information obtained from 189 WHO grade II glioma patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2020.03.008DOI Listing

Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas.

Cancer Res Treat 2020 Apr 23. Epub 2020 Apr 23.

Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.

Purpose: The aim of this study is to evaluate the survival rate and prognostic factors of anaplastic gliomas according to the 2016 World Health Organization classification, including extent of resection (EOR) as measured by contrast-enhanced T1-weighted magnetic resonance imaging (MRI) and the T2-weighted MRI.

Materials And Methods: The records of 113 patients with anaplastic glioma who were newly diagnosed at our institute between 2000 and 2013 were retrospectively reviewed. There were 62 cases (54. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2020.057DOI Listing

Implementation of clinical tractography for pre-surgical planning of space occupying lesions: An investigation of common acquisition and post-processing methods compared to dissection studies.

PLoS One 2020 14;15(4):e0231440. Epub 2020 Apr 14.

Institute of Psychiatry, Psychology and Neuroscience, King's College London, Institute of Psychiatry, London, England, United Kingdom.

Background And Purpose: There is limited standardization of acquisition and processing methods in diffusion tractography for pre-surgical planning, leading to a range of approaches. In this study, a number of representative acquisition variants and post processing methods are considered, to assess their importance when implementing a clinical tractography program.

Methods: Diffusion MRI was undertaken in ten healthy volunteers, using protocols typical of clinical and research scanning: a 32-direction diffusion acquisition with and without peripheral gating, and a non-gated 64 diffusion direction acquisition. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231440PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156092PMC
July 2020
3.234 Impact Factor

Involvement of the Olfactory Apparatus by Gliomas.

AJNR Am J Neuroradiol 2020 04 12;41(4):712-717. Epub 2020 Mar 12.

Radiology (S.C.).

The olfactory bulbs and tracts are central nervous system white matter tracts maintained by central neuroglia. Although rare, gliomas can originate from and progress to involve the olfactory apparatus. Through a Health Insurance Portability and Accountability Act-compliant retrospective review of the institutional teaching files and brain MR imaging reports spanning 10 years, we identified 12 cases of gliomas involving the olfactory bulbs and tracts, including 6 cases of glioblastoma, 2 cases of anaplastic oligodendroglioma, and 1 case each of pilocytic astrocytoma, diffuse (grade II) astrocytoma, anaplastic astrocytoma (grade III), and diffuse midline glioma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3174/ajnr.A6471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144643PMC

Segmentation and Classification in Digital Pathology for Glioma Research: Challenges and Deep Learning Approaches.

Front Neurosci 2020 21;14:27. Epub 2020 Feb 21.

Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Biomedical imaging Is an important source of information in cancer research. Characterizations of cancer morphology at onset, progression, and in response to treatment provide complementary information to that gleaned from genomics and clinical data. Accurate extraction and classification of both visual and latent image features Is an increasingly complex challenge due to the increased complexity and resolution of biomedical image data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnins.2020.00027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046596PMC
February 2020

Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients.

Neurosurgery 2020 Feb 28. Epub 2020 Feb 28.

Centre de recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR 5286, Cancer Cell Plasticity department, Transcriptome Diversity in Stem Cells laboratory, Lyon, France.

Background: Biopsies in patients with a suspected glioma are occasionally nondiagnostic.

Objective: To explore the utility of molecular testing in this setting by determining whether IDH1 and TERT promoter (pTERT) mutations could be detected in nondiagnostic biopsies from glioma patients.

Methods: Using SNaPshot polymerase chain reaction, we retrospectively assessed IDH1 and pTERT mutation status in nondiagnostic biopsies from 28 glioma patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyaa025DOI Listing
February 2020

Better efficacy in differentiating WHO grade II from III oligodendrogliomas with machine-learning than radiologist's reading from conventional T1 contrast-enhanced and fluid attenuated inversion recovery images.

BMC Neurol 2020 Feb 7;20(1):48. Epub 2020 Feb 7.

Department of Radiology & Functional and Molecular Imaging Key Lab of Shaanxi Province, Tangdu Hospital, Air Force Medical University, 569 Xinsi Road, Xi'an, 710038, Shaanxi, People's Republic of China.

Background: The medical imaging to differentiate World Health Organization (WHO) grade II (ODG2) from III (ODG3) oligodendrogliomas still remains a challenge. We investigated whether combination of machine leaning with radiomics from conventional T1 contrast-enhanced (T1 CE) and fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) offered superior efficacy.

Methods: Thirty-six patients with histologically confirmed ODGs underwent T1 CE and 33 of them underwent FLAIR MR examination before any intervention from January 2015 to July 2017 were retrospectively recruited in the current study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-020-1613-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007642PMC
February 2020
2.040 Impact Factor

Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.

Neuro Oncol 2020 Jul;22(7):993-1005

Department of Neurosurgery, University Hospital Group for Psychiatry and Neurosciences (GHU)-Sainte-Anne Hospital, Paris, France.

Background: We quantified the spontaneous imaging growth rate of oligodendrogliomas. We assessed whether (i) it discriminates between World Health Organization (WHO) grade II and grade III oligodendrogliomas, and (ii) grade III oligodendrogliomas with neo-angiogenesis are associated with more fast growth rates (≥8 mm/y).

Methods: This work employed a retrospective bicentric cohort study (2010-2016) of adult patients harboring a newly diagnosed supratentorial oligodendroglioma, isocitrate dehydrogenase (IDH) mutant and 1p/19q codeleted (WHO 2016 classification), with a minimum of 2 available MRIs before any treatment (minimum 6-week interval) to measure the spontaneous tumor growth rate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noaa022DOI Listing

Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.

J Neurosurg 2020 Jan 24:1-11. Epub 2020 Jan 24.

1Department of Neurosurgery.

Objective: High-grade glioma (HGG) prognosis remains dismal, with inevitable, mostly local recurrence. Regimens for improving local tumor control are therefore needed. Photodynamic therapy (PDT) using porfimer sodium has been investigated but was abandoned due to side effects and lack of survival benefits. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2019.11.JNS192443DOI Listing
January 2020

Ability of Radiomics in Differentiation of Anaplastic Oligodendroglioma From Atypical Low-Grade Oligodendroglioma Using Machine-Learning Approach.

Front Oncol 2019 17;9:1371. Epub 2019 Dec 17.

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.

To investigate the ability of radiomics features from MRI in differentiating anaplastic oligodendroglioma (AO) from atypical low-grade oligodendroglioma using machine-learning algorithms. A total number of 101 qualified patients (50 participants with AO and 51 with atypical low-grade oligodendroglioma) were enrolled in this retrospective, single-center study. Forty radiomics features of tumor images derived from six matrices were extracted from contrast-enhanced T1-weighted (T1C) images and fluid-attenuation inversion recovery (FLAIR) images. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.01371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929242PMC
December 2019

Diffuse Leptomeningeal Glioneuronal Tumor: A Unique Leptomeningeal Tumor Entity.

World Neurosurg 2020 Mar 30;135:297-300. Epub 2019 Dec 30.

Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India.

Background: Diffuse leptomeningeal glioneuronal tumor (DLGNT) is a recent addition to the World Health Organization classification schema of brain tumors, under the heading of neuronal and mixed neuronal-glial tumors. DLGNTs have a classic imaging appearance. However, it has often been misdiagnosed owing to its rarity, its resemblance to granulomatous/leptomeningeal etiologies, and the clinical presentation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.12.119DOI Listing

Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.

Pathol Int 2020 Jan 19;70(1):40-46. Epub 2019 Dec 19.

Department of Human Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.

We report a histological and genetic study of concurrent oligodendroglioma and a microscopic pleomorphic xanthoastrocytoma (PXA)-like lesion in a 48-year-old male. He presented with generalized seizure, and magnetic resonance imaging revealed a nonenhanced left frontal lobe mass suggesting low-grade glioma. The patient underwent craniotomy and tumor resection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12880DOI Listing
January 2020

Advanced imaging in adult diffusely infiltrating low-grade gliomas.

Insights Imaging 2019 Dec 18;10(1):122. Epub 2019 Dec 18.

Selcuk University, Konya, Turkey.

The adult diffusely infiltrating low-grade gliomas (LGGs) are typically IDH mutant and slow-growing gliomas having moderately increased cellularity generally without mitosis, necrosis, and microvascular proliferation. Supra-total resection of LGG significantly increases the overall survival by delaying malignant transformation compared with a simple debulking so accurate MR diagnosis is crucial for treatment planning. Data from meta-analysis support the addition of diffusion and perfusion-weighted MR imaging and MR spectroscopy in the diagnosis of suspected LGG. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13244-019-0793-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920302PMC
December 2019

High-grade Glioma Masquerading as a Small Cerebral Hemorrhage: A Case Report.

Yonago Acta Med 2019 Dec 18;62(4):305-307. Epub 2019 Oct 18.

Division of Neurosurgery, Department of Brain and Neurosciences, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.

We report a rare case of a high-grade glioma masquerading as a small subcortical hemorrhage. A 71-year-old woman came to a local hospital with sudden right upper extremity numbness. Computed tomography revealed a small subcortical hemorrhage with faint perifocal edema in the left postcentral gyrus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.33160/yam.2019.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872950PMC
December 2019

The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.

Neurosurg Focus 2019 12;47(6):E13

1Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota; and.

Objective: With the revised WHO 2016 classification of brain tumors, there has been increasing interest in imaging biomarkers to predict molecular status and improve the yield of genetic testing for diffuse low-grade gliomas (LGGs). The T2-FLAIR-mismatch sign has been suggested to be a highly specific radiographic marker of isocitrate dehydrogenase (IDH) gene mutation and 1p/19q codeletion status in diffuse LGGs. The presence of T2-FLAIR mismatch indicates a T2-hyperintense lesion that is hypointense on FLAIR with the exception of a hyperintense rim. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2019.9.FOCUS19660DOI Listing
December 2019

Radiomics-Based Machine Learning Technology Enables Better Differentiation Between Glioblastoma and Anaplastic Oligodendroglioma.

Front Oncol 2019 5;9:1164. Epub 2019 Nov 5.

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.

The aim of this study was to test whether radiomics-based machine learning can enable the better differentiation between glioblastoma (GBM) and anaplastic oligodendroglioma (AO). This retrospective study involved 126 patients histologically diagnosed as GBM ( = 76) or AO ( = 50) in our institution from January 2015 to December 2018. A total number of 40 three-dimensional texture features were extracted from contrast-enhanced T1-weighted images using LIFEx package. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.01164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848260PMC
November 2019

IDH-1 polymorphisms in pilocytic astrocytomas.

Ann Diagn Pathol 2019 Dec 23;43:151411. Epub 2019 Oct 23.

Department of Anatomic Pathology, L25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address:

As of 2016, isocitrate dehydrogenase (IDH)-1 and IDH-2 mutations are part of the definition of an oligodendroglioma and may be seen in a significant subset of grade II-IV fibrillary astrocytomas. Reports of IDH-1 and IDH-2 alterations in pilocytic astrocytomas have been rare. This study reports two cases of pilocytic astrocytomas which harbored IDH-1 polymorphisms (G105G) (c. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anndiagpath.2019.151411DOI Listing
December 2019

Temporoinsular Glioma Resection under Awake Mapping: 2-Dimensional Operative Video.

Oper Neurosurg (Hagerstown) 2020 Jul;19(1):E54

Neurologic Surgery Department of Huashan Hospital, Fudan University, Shanghai, China.

Temporoinsular gliomas are frequently large-sized tumors that require meticulous planning to ensure maximum surgical resection and minimal neurologic deficits in patients. Here, we demonstrate our technique encompassing multi-modal imaging guidance and awake brain mapping which enables maximum safe resection of such tumors. The patient, a 39-yr-old man, presented with depression and memory loss for 18 mo. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ons/opz295DOI Listing
July 2020
1 Read

A challenging case of concurrent multiple sclerosis and anaplastic astrocytoma.

Surg Neurol Int 2019 23;10:166. Epub 2019 Aug 23.

Department of Neuropathology, Karolinska University Hospital, Stockholm, Sweden.

Background: Cases of gliomas coexisting with multiple sclerosis (MS) have been described over the past few decades. However, due to the complex clinical and radiological traits inherent to both entities, this concurrent phenomenon remains difficult to diagnose. Much has been debated about whether this coexistence is incidental or mirrors a poorly understood neoplastic phenomenon engaging glial cells in the regions of demyelination. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.25259/SNI_176_2019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763678PMC
August 2019
1 Read

Measurement of Active Motor Threshold Using a Dynamometer During Navigated Transcranial Magnetic Stimulation in a Patient with Postoperative Brain Tumor: Technical Note.

World Neurosurg 2020 Jan 21;133:42-48. Epub 2019 Sep 21.

National Cancer Institute, Rio de Janeiro, RJ, Brazil.

Background: Navigated transcranial magnetic stimulation (nTMS) is being used for different purposes in patients with brain tumors. However, the procedure requires a positive electrophysiological response. For patients with negative response in rest conditions, active motor threshold (AMT) may be used. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18788750193251
Publisher Site
http://dx.doi.org/10.1016/j.wneu.2019.09.080DOI Listing
January 2020
3 Reads

Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.

Neuro Oncol 2020 03;22(3):412-422

Brain Tumor Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.

Background: Surgical resection and irradiation of diffuse glioma are guided by standard MRI: T2/fluid attenuated inversion recovery (FLAIR)-weighted MRI for non-enhancing and T1-weighted gadolinium-enhanced (T1G) MRI for enhancing gliomas. Amino acid PET has been suggested as the new standard. Imaging combinations may improve standard MRI and amino acid PET. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noz180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058442PMC
March 2020
1 Read

Oligodendroglioma confers higher risk of radiation necrosis.

J Neurooncol 2019 Nov 23;145(2):309-319. Epub 2019 Sep 23.

Department of Neurology, Division of Neuro-Oncology, University of Virginia Health System, P.O. Box 800432, Charlottesville, VA, 22908, USA.

Background: Radiation therapy (RT) remains a mainstay for the treatment of lower grade gliomas. Radiation neurotoxicity is a serious complication, carrying high morbidity in the absence of tumor progression. The incidence remains poorly categorized and known risk factors identified are related to the radiation modality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03297-7DOI Listing
November 2019
2 Reads

Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

Neuro Oncol 2019 11;21(11):1470-1479

Neuro-Oncology Unit, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-Catalan Institute of Oncology (IDIBELL) (Oncobell program), Barcelona, Spain.

Background: We identify cognitive impairment and MRI structural brain changes in long-term oligodendroglial tumor survivors treated with radiation therapy (RT) alone (21%) or with chemotherapy (CT) (79%).

Methods: Oligodendroglial tumor patients (based on the World Health Organization [WHO] 2007 classification) who completed RT ± CT at least 2 years before the study initiation, were classified into 3 groups according to the time treatment was completed: Group 1 = 2-5 years (n = 22), Group 2 = 6-10 years (n = 13), and Group 3 >10 years (n = 13). All patients had a cross-sectional neuropsychological evaluation (n = 48) and a longitudinal volumetric analysis (gray matter [GM; n = 34]) between postsurgical and last follow-up MRI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noz130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827827PMC
November 2019
1 Read

Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

J Neurosurg 2019 Aug 16:1-10. Epub 2019 Aug 16.

4Neurosurgery, Gifu University Graduate School of Medicine, Gifu; and.

Objective: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. Read More

View Article

Download full-text PDF

Source
https://thejns.org/view/journals/j-neurosurg/aop/article-10.
Publisher Site
http://dx.doi.org/10.3171/2019.5.JNS19780DOI Listing
August 2019
6 Reads

Multiparametric and multiregional diffusion features help predict molecule information, grade and survival in lower-grade gliomas: a feasibility study.

Br J Radiol 2019 Nov 9;92(1103):20190324. Epub 2019 Aug 9.

Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

Objective: This study was to investigate the relationship of diffusion features with molecule information, and then predict grade and survival in lower-grade gliomas.

Methods: 65 patients with primary lower-grade gliomas (WHO Grade II & III) who underwent conventional MRI and diffusion tensor imaging were retrospectively studied. The tumor region was automatically segmented into contrast-enhancing tumor, non-enhancing tumor, edematous and necrotic volumes. Read More

View Article

Download full-text PDF

Source
https://www.birpublications.org/doi/10.1259/bjr.20190324
Publisher Site
http://dx.doi.org/10.1259/bjr.20190324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849676PMC
November 2019
1 Read

Radiation-induced osteosarcoma of the calvarium in a patient of left frontal oligodendroglioma following surgery and radiotherapy.

Neurol India 2019 May-Jun;67(3):869-870

Department of Radiology and Imaging, Fortis Memorial Research Institute, Gurgaon and SRL-FMRI Diagnostics, Gurgaon, Haryana, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0028-3886.263209DOI Listing
March 2020
5 Reads

Radiomics Analysis for Glioma Malignancy Evaluation Using Diffusion Kurtosis and Tensor Imaging.

Int J Radiat Oncol Biol Phys 2019 11 22;105(4):784-791. Epub 2019 Jul 22.

Department of Neurosurgery, University of Tokyo, Tokyo.

Purpose: A noninvasive diagnostic method to predict the degree of malignancy accurately would be of great help in glioma management. This study aimed to create a highly accurate machine learning model to perform glioma grading.

Methods And Materials: Preoperative magnetic resonance imaging acquired for cases of glioma operated on at our institution from October 2014 through January 2018 were obtained retrospectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.07.011DOI Listing
November 2019
3 Reads

[Difficulties in distinguishing abnormal intensities associated with convulsion from tumor on MRI: a case report].

Rinsho Shinkeigaku 2019 Aug 23;59(8):515-519. Epub 2019 Jul 23.

Department of Neurology, Yodogawa Christian Hospital.

A 48-year-old man was admitted to our department with generalized convulsive seizures followed by recurrent partial clonic convulsions in the left face and arm. Convulsions stopped temporarily after administration of diazepam, fosphenytoin, and levetiracetam. However, frequent partial seizures occurred repeatedly and general anesthesia was required to control seizures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5692/clinicalneurol.cn-001289DOI Listing
August 2019
2 Reads

Real-time augmented reality for delineation of surgical margins during neurosurgery using autofluorescence lifetime contrast.

J Biophotonics 2020 Jan 9;13(1):e201900108. Epub 2019 Aug 9.

Department Biomedical Engineering, University of California, Davis, California.

Current clinical brain imaging techniques used for surgical planning of tumor resection lack intraoperative and real-time feedback; hence surgeons ultimately rely on subjective evaluation to identify tumor areas and margins. We report a fluorescence lifetime imaging (FLIm) instrument (excitation: 355 nm; emission spectral bands: 390/40 nm, 470/28 nm, 542/50 nm and 629/53 nm) that integrates with surgical microscopes to provide real-time intraoperative augmentation of the surgical field of view with fluorescent derived parameters encoding diagnostic information. We show the functionality and safety features of this instrument during neurosurgical procedures in patients undergoing craniotomy for the resection of brain tumors and/or tissue with radiation damage. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.2019001
Publisher Site
http://dx.doi.org/10.1002/jbio.201900108DOI Listing
January 2020
3 Reads

Anaplastic Oligodendroglioma with Transdural Extension.

World Neurosurg 2019 Oct 26;130:10-12. Epub 2019 Jun 26.

Department of Diagnostic Radiology, Ng Teng Fong General Hospital, Singapore.

Oligodendrogliomas, the third most common primary gliomas, have a strict molecular definition, characterized by the combined presence of isocitrate dehydrogenase mutation and 1p19q codeletion. Herein, we describe an extremely unusual case of molecularly defined anaplastic oligodendroglioma with transdural extension into the frontal and ethmoid sinuses, without prior neurosurgical intervention or radiotherapy. The molecular profile of the tumor is also provided. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.06.146DOI Listing
October 2019
11 Reads
2.417 Impact Factor

Diffuse Low-Grade Glioma - Changing Concepts in Diagnosis and Management: A Review.

Asian J Neurosurg 2019 Apr-Jun;14(2):356-363

Department of Surgery, The Aga Khan University Hospital, Karachi, Pakistan.

Though diffuse low-grade gliomas (dLGGs) represent only 15% of gliomas, they have been receiving increasing attention in the past decade. Significant advances in knowledge of the natural history and clinical diversity have been documented, and an improved pathological classification of gliomas that integrates histological features with molecular markers has been issued by the WHO. Advances in the radiological assessment of dLGG, particularly new magnetic resonance imaging scanning sequences, allow improved diagnostic and prognostic information. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ajns.AJNS_24_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516028PMC
May 2019
21 Reads

Scalp Metastasis of Anaplastic Oligodendroglioma.

World Neurosurg 2019 Aug 21;128:448-451. Epub 2019 May 21.

Department of Neurosurgery, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Electronic address:

Background: Scalp metastases from anaplastic oligodendroglioma (AO) are extremely rare and mostly involve intracranial recurrence or widely metastatic disease. Here we describe an exceptional case of histopathologically proven scalp metastasis of AO 6 years after surgical resection and postoperative adjuvant radiation.

Case Description: A 42-year-old woman presented with several months of progressive headache and dizziness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.05.109DOI Listing
August 2019
8 Reads

Neurosurgical Flexible Probe Microscopy with Enhanced Architectural and Cytological Detail.

World Neurosurg 2019 Aug 14;128:e929-e937. Epub 2019 May 14.

Goodman Campbell Brain and Spine and Indiana University Department of Neurological Surgery, Indianapolis, Indiana, USA. Electronic address:

Background: Microscopic delineation and clearance of tumor cells at neurosurgical excision margins potentially reduce tumor recurrence and increase patient survival. Probe-based in vivo fluorescence microscopy technologies are promising for neurosurgical in vivo microscopy.

Objective: We sought to demonstrate a flexible fiberoptic epifluorescence microscope capable of enhanced architectural and cytological imaging for in vivo microscopy during neurosurgical procedures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.05.039DOI Listing
August 2019
4 Reads

Leksell Radiosurgery for Ependymomas and Oligodendrogliomas.

Prog Neurol Surg 2019 16;34:200-206. Epub 2019 May 16.

Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Stereotactic radiosurgery (SRS) has become a standard management option for less common glial tumors. When imaging defines a recurrent or progressive ependymoma after initial resection in a child who has completed adjuvant fractionated radiation therapy, SRS may be used as a boost or salvage strategy. For patients with oligodendrogliomas diagnosed by biopsy or after cytoreductive surgery, SRS may be used as a primary option in smaller volume tumors, or as an adjuvant option for tumors that have progressed after initial surgery, chemotherapy, or fractionated radiation therapy. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/493065
Publisher Site
http://dx.doi.org/10.1159/000493065DOI Listing
December 2019
3 Reads

Staged Laser Interstitial Thermal Therapy (LITT) Treatments to Left Insular Low-Grade Glioma.

Neurosurgery 2020 03;86(3):E337-E342

Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri.

Background And Importance: Low-grade insular gliomas remain challenging tumors for aggressive resection because of the numerous functional and vascular structures surrounding them. Because of the potential morbidities associated with open surgical resection, less invasive techniques may confer a more optimal balance between cytoreduction and surgical complications. For this reason, we evaluated the use of laser interstitial thermal therapy (LITT) for resection of a dominant hemisphere oligodendroglioma World Health Organization (WHO) grade II in a 68-yr-old patient by use of multiple staged surgeries for its resection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyz120DOI Listing
March 2020
5 Reads

Prognostic Value of O-(2-[F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.

Mol Imaging Biol 2019 12;21(6):1174-1181

Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Wurzburg, Germany.

Purpose: The use of [F]fluoroethyl)-L-tyrosine ([F]FET) positron emission tomography/computed tomography (PET/CT) has proven valuable in brain tumor management. This study aimed to investigate the prognostic value of radiotracer uptake in newly diagnosed grade II or III gliomas according to the current 2016 World Health Organization (WHO) classification.

Procedures: A total of 35 treatment-naive patients (mean age, 48 ± 17 years) with histologically proven WHO grade II or III gliomas as defined by the current 2016 WHO classification were included. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11307-019-01357-y
Publisher Site
http://dx.doi.org/10.1007/s11307-019-01357-yDOI Listing
December 2019
30 Reads

Glioma Simultaneously Present with Adjacent Meningioma: Case Report and Literature Review.

Asian J Neurosurg 2019 Jan-Mar;14(1):272-274

Department of Neurosurgery, Paras Hospital, Gurgaon, Haryana, India.

A 51-year-old male patient presented to us with an episode of generalized tonic-clonic seizure. Magnetic resonance imaging revealed a dural-based contrast-enhancing lesion in the right temporal lobe and another heterogeneously contrast-enhancing intra-axial lesion in the right insula adjacent to it. Histopathology confirmed it as a meningioma adjacent to an anaplastic oligodendroglioma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ajns.AJNS_308_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417352PMC
April 2019
18 Reads

Case Report of Rarely Described Polymorphous Low-Grade Neuroepithelial Tumor of the Young and Comparison with Oligodendroglioma.

World Neurosurg 2019 Jul 26;127:47-51. Epub 2019 Mar 26.

Department of Pathology, Round Rock, Texas, USA.

Background: Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a central nervous system tumor that shares many qualities with oligodendroglioma but is rarely and only very recently described as a distinct entity in the literature.

Case Description: A previously healthy, 19-year-old man presented with new onset of seizures. Imaging showed an intracranial mass, which was treated with surgical removal. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.03.181DOI Listing
July 2019
6 Reads